ABSTRACT. Atrial natriuretic factor (ANF) is a class of ANF is a class of potent diuretic and natriuretic peptides diuretic and natriuretic peptides secreted by mammalian secreted by mammalian cardiac atria (1, 2). ANF may have a cardiac atria. Although basal plasma ANF levels in the central role in the regulation of adult fluid and electrolyte hoovine fetus are elevated relative to the adult, fetal secretion meostasis. There are data to suggest that ANF may regulate in of ANF increases in response to intravascular isotonic utero fluid dynamics in the mammalian (ovine) fetus (3, 4); saline infusion. Recent in vitro and in vivo studies indicate preliminary studies have indicated a significant diuretic and that ANF secretion also may be stimulated by increased natriuretic (4, 5) effect of plasma ANF in the ovine fetus. Basal plasma osmolality and/or sodium concentration. The pres-plasma ANF levels in the ovine fetus are elevated in comparison ent studies were conducted to determine if volume expan-to the adult (3, 6). Yet, despite these elevated levels, the ovine sion associated with increased plasma osmolality would fetus is capable of increased secretion of ANF in response to further augment ANF secretion in the ovine fetus. In intravascular saline infusion (6). response to successive 30-min intravenous infusions of 3% ANF release occurs in response to intravascular volume exsaline at 0.5 and 1.0 ml/kg/min fetal plasma ANF signifi-pansion with atrial stretch believed to be the actual stimulus. cantly increased from a basal level of 98 f 31 pg/ml to a Recent in vitro (7, 8) and in vivo (9-1 1) studies in adults indicate peak of 439 f 42 pg/ml ( p < 0.05). During a 30-min that ANF secretion from atrial myocytes also may be stimulated postinfusion recovery period, fetal plasma ANF signifi-by increased plasma osmolality and/or sodium concentration. cantly decreased from peak values to 224 f 10 pg/ml (p In the present studies we sought to determine if volume expan-< 0.05), although remaining above basal levels. Fetal sion associated with increased plasma osmolality would further plasma osmolality significantly increased from 300 + 2 augment ANF secretion in the ovine fetus. mosmol to 325 f 3 mosmol ( p < 0.05) whereas fetal plasma arginine vasopressin increased from 1.9 f 0.4 to 10.9 + 7.0 pg/ml ( p < 0.05) at the conclusion of the 3% MATERIALS AND METHODS saline infusion. During the saline infusion a significant Animals and surgery. Studies were performed in five mixedincrease in fetal heart rate and decrease in fetal hematocrit breed Western cross-bred ewes with singleton fetuses ranging in were noted. Fetal blood pressure and maternal plasma ANF age from 129 to 136 days (mean gestational age = 134 ? 1 day). and arginine vasopressin concentrations remained un-Animals were housed indoors in individual steel study cages and changed. Despite the potential stimulatory effects of hy-maintained under a controlled lighting regime of 12 h of light perosmolality, increased plasma arginine vasopressin, and and 12 h of darkness. Food (alfalfa pellets) and water were intravascular volume expansion, the increase in fetal available ad libitum except for the withholding of food during plasma ANF in the present study did not exceed that the 24-h period immediately preceding surgery. induced by isotonic saline alone. These results suggest that Anesthesia for surgery was induced by an intramuscular injecplasma osmolality does not act additively with intravascu-tion of ketamine hydrochloride (20 mg/kg) plus atropine-sulfate lar volume loading for stimulation of ANF secretion in the (30 ,~g/kg), and subsequently maintained by a continuous intraovine fetus. (Pediatr Res 24: 318-321,1988) venous infusion of ketamine (15 mg/kg/h). Xylocaine (1 %) was applied locally before all incisions. The uterus was exposed by a Abbreviations midline abdominal incision and a small hysterotomy was performed to provide access to a single fetal hindlimb. Tygon ANF, atrial natriuretic factor catheters (1 mm ID; 1.8 mm OD) were placed in the fetal dorsal AVP, arginine vasopressin hindlimb vein and artery and threaded to the inferior vena cava RIA, radioimmunoassay and abdominal aorta, respectively. Before hysterotomy closure, a plastic catheter (Corometerics Medical Systems, Wallingford, CT) was sutured to the distal tip of the fetal hindlimb to provide access to the amniotic cavity. The maternal femoral artery and
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Experimental protocol. A minimum of 5 days of postoperative recovery was permitted before study. All experiments were performed in unanesthetized ewes standing in the same individual cages in which they were maintained. During the study, the side walls of the cages were gently compressed, restricting lateral movement. Fetal arterial blood pH was assessed and the studies undertaken only if the fetal pH was more than 7.3. The study was divided into four 30-min periods: a control period (time -30 to 0 rnin), two hypertonic saline infusion periods, and a recovery period. At time 0 min, a fetal intravenous infusion of warmed 3% saline (0.5 ml/kg/min) was initiated and maintained for 30 min. At time +30 min, the hypertonic saline infusion was increased to 1.0 ml/kg/min for another 30 min. At +60 min, the infusion was discontinued and the fetus observed for a 30-min recovery period. Infusion rates were based on estimated fetal body weights from the formula: fetal body weight (kg) = [0.096
x gestational age (days)] -9.2228, as described by Robillard and
Weitzman ( 12) . Fetal and maternal arterial blood samples (5.0 ml) were collected at 15 and 30 min of the control period and subsequent blood samples were collected at 10-min intervals after initiation of the saline infusion. Repeat samples of maternal arterial blood were drawn at 20 and 30 min of the 1.0 ml/kg/min infusion. Blood samples (2.5 ml) were allocated into iced tubes containing traysylol(250 KIU/ml blood), trypsin inhibitor (40 pU/ml), and K2 EDTA (1 mg/ml) for subsequent determination of plasma ANF. Hematocrit determinations were performed in triplicate on each blood sample. All samples were centrifuged immediately. Osmolality was measured in aliquots of the prepared plasma. Additional samples of fetal arterial blood were drawn at 15 and 30 min of the basal period and at the conclusion of each infusion and recovery period; 2.0 ml of blood were placed into iced tubes containing 20 pl of 15% K EDTA for subsequent determination of AVP and 0.5 ml was collected into heparinized syringes for determination of pH, p02, and pc02. The total volume of fetal blood withdrawn at each sample was replaced with an equal volume of heparinized maternal blood withdrawn before the study. Plasma was stored at -20" C until assayed for AVP and ANF.
Fetal arterial blood pressure and amniotic cavity pressures were monitored continuously by means of a Beckman R-612 physiological recorder (Beckman, Palo Alto, CA) with Statham P23 transducers. Fetal blood pressure was corrected for amniotic fluid pressures and fetal heart rate was computed from the arterial pulse.
Analytical methods. Plasma ANF determinations were performed by a recently described (6, 13) RIA developed in our laboratory. Plasma samples were acidified with 100 pl of 1 N HCl and extracted on C 18 Sep-Pac columns (Waters Associates, Milford. MA). A tvluical ANF RIA standard curve ranged from 1 to 500 pg/t;be, Sotted as B/Bo versus pg/tube. The &esitivity of the assay, defined as the least amount of ANF distinguishable from 0 at the 95% confidence limit, was 2 pg/tube. Although our antiserum is 100% cross-reactive with hANF [ l-28 amino acids (aa)], rat ANF (1-28 aa) is only 43%; cross-reaction with a variety of synthetic ANF analogues is minimal (6) .
The mean recoveries of synthetic hANF added to pools of either ovine adult plasma ( n = 10) or fetal plasma ( n = 10) were similar (81 & 6 and 85 +: 5%, respectively). Recovery of '251-labeled ANF was also similar (78 + 3%). The intraassay and interassay coefficients of variation were 1 1 and 13%, respectively. Fetal and maternal plasma AVP concentrations were determined by RIA as previously described (14) . Plasma samples were extracted by use of Sep Pak columns (Water Associates) using the method of LaRochelle et al. (15) . The AVP RIA is sensitive to 0.8 pg of AVP/ml plasma (0.16 pg/tube) with 50% displacement of labeled ligand observed at plasma concentrations of 4 pg/ml. The intraassay and interassay coefficients of variation were 6 and 8%, respectively. Recovery of added synthetic AVP (lot R50015, Bachem, Torrance, CA) averaged 70%.
Blood pH, pol, and pco2 values were determined at 39" C with ANF (224 f 10 pg/ml), osmolality (315 & 4 mosmol), and hematocrit (3 1.2 -1-1.5%) returned toward basal values. However, plasma AVP (10.9 f 7.1 pg/ml) remained elevated at the conclusion of the recovery period. Plasma ANF increased in proportion to the rate of the 3% saline infusion. In response to the low dose 3% saline infusion, there was a small but nonsignificant increase in the mean infusion period plasma ANF values (98.5 + 27.9 to 174.4 + 22.9 pg/ ml), although there was a statistically significant increase at the +20-min samples (Fig. 1) . The high dose infusion was associated with a significant increase in mean plasma ANF (365.2 + 25.8 pg/ml). Although levels decreased significantly during the recov- There were no significant changes in fetal systolic, diastolic, or mean blood pressure during the course of the study. Mean fetal pH decreased during the 1 ml/kg/min infusion of 3% saline rate increased significantly during the infusions 178 f 9 to 208 + 12 beatslmin, returning toward baseline at the end of the recovery period. DISCUSSION Previously it has been demonstrated that basal ovine fetal plasma ANF levels are significantly more than maternal levels (3, 6, 13, 16 ). We also demonstrated that isotonic (0.9%) saline infusion to the fetus at rates identical to those used in the present study (0.5 and 1.0 ml/kg/min) resulted in an increase in fetal plasma ANF from 115 + 24 pg/ml to a maximum of 409 + 72 pg/ml (6) . Peak values were achieved during the high dose isotonic saline infusion; during the postinfusion recovery period plasma ANF decreased toward basal levels.
In the present study, graded intravenous infusions of 3% saline to the ovine fetus resulted in a significant increase in plasma ANF concentration. Mean plasma ANF increased from a basal value of 98 + 31 pg/ml to a maximum of 439 + 42 pg/ml, a time-course and maximal response similar to that previously observed during isotonic volume loading (6) . In addition, in response to hypertonic saline infusion, plasma osmolality and AVP concentrations also significantly increased. Previous control studies with similar fetal blood sampling protocols resulted in no change in plasma AVP concentrations or cardiovascular parameters (17) .
The primary stimuli for ANF secretion appear to be increased atrial pressure or stretch ( I , 2). Despite elevated basal levels, the late gestation ovine fetus responds to acute intravascular volume expansion with a further increase in ANF secretion (6) . As there does not appear to be a noncirculating pool of red blood cells in the ovine fetus (18) , the decrease in hematocrit in our study indicates fetal plasma volume expansion. The correlation of fetal plasma ANF levels and hematocrit suggests that volume expansion contributed to the increase in ANF secretion.
Hyperosmolality also has been demonstrated to increase ANF secretion in vivo in dogs, rats, and humans (9-1 1). It has been proposed that this increase in plasma ANF is mediated by atrial pressure changes secondary to fluid shifts from the interstitial to the intravascular compartment. However, hyperosmolality and/ or hypernatremia have been demonstrated to increase ANF secretion from spontaneously beating rat atria in vitro as well as from isolated atrial myocytes (7, 8) . In the present study, the increase in plasma ANF concentration correlated significantly with the changes in plasma osmolality as well as hematocrit. Yet, the increase in plasma ANF during the 3% saline infusion was similar to the increase noted during isotonic (0.9%) saline infusion. Therefore, although osmolality may contribute directly to the secretion of ANF, it does not appear to act additively with intravascular volume loading in the ovine fetus.
As a complicating factor, AVP may affect ANF release. In vitro, AVP stimulation of ANF secretion has been demonstrated in isolated atrial tissue (19) . In adult rats in vivo studies using pharmacologic levels of AVP have demonstrated that ANF secretion increases in proportion to vasopressor-induced increases in systemic and atrial pressures (20) . In rat fetuses intraperitoneal injection of AVP resulted in increased fetal plasma ANF, although plasma levels of AVP and cardiovascular responses were not determined (21) . In our study the increase in fetal plasma AVP was not of sufficient magnitude to increase fetal systemic blood pressure. As steady-state plasma AVP levels three to four times those achieved in the present study do not affect ovine fetal ANF secretion (22) , it is probable that plasma AVP did not significantly affect fetal ANF secretion.
The increase in both plasma ANF and AVP may result in competitive physiologic effects. Whereas ANF has been demonstrated to increase heart rate (23), AVP may have direct cardiac depressant effects. The increase in fetal heart rate in the present study is consistent with the fetal tachycardia induced by exogenous infusion of ANF to the fetus (16) . Thus at the plasma hormone levels achieved in the present study, the ANF cardiovascular effects appear to predominate. It is unknown if ANF diuretic properties induce a similar antagonism of AVP-mediated renal antidiuresis in the fetus.
During the recovery period, fetal hematocrit, plasma ANF, plasma osmolality, and heart rate returned toward basal values. In contrast, fetal plasma AVP concentration remained elevated. The apparent continued increased AVP secretion may be due to the sustained elevation in plasma osmolality above threshold levels, as well as a previously demonstrated prolongation of AVP secretion after stimulation (24) . Thus although AVP and ANF may be counterregulatory hormones, with regard to both secretion and function, ANF appears to be a more acute phase reactant.
In summary, hypertonic saline infusion to the ovine fetus resulted in significant increases in both plasma AVP and ANF concentrations. Despite stimulatory effects of hyperosomolality, increased plasma AVP, and intravascular volume expansion, ANF plasma levels did not exceed those previously induced by isotonic saline alone. These results suggest that osmolality does not act additively with intravascular volume expansion in stimulating ovine fetal secretion of ANF.
